Mesothelioma
Who we are
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies